Cystatin C is not affected by age, gender, muscle mass, or ethnicity and is more sensitive than GFR in detecting acute kidney injury [29], and it is a biomarker for cardiovascular disease [30] and for CKD [31]. This evidence concerns the gene CST3 and acute kidney injury.